SYNH Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 0.34%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Syneos Health Insider Trading History Chart

This chart shows the insider buying and selling history at Syneos Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1M$0$1MTotal Insider BuyingTotal Insider Selling

Syneos Health Share Price & Price History

Current Price: $42.98
Price Change: Price Increase of +0.01 (0.02%)
As of 09/28/2023 09:00 PM ET

This chart shows the closing price history over time for SYNH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

SEC Filings (Institutional Ownership Changes) for Syneos Health (NASDAQ:SYNH)

91.16% of Syneos Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SYNH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
202220232024$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4-$600M-$400M-$200M$0$200M$400M$600MTotal InflowsTotal Outflows
Syneos Health logo
Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.
Read More on Syneos Health

Today's Range

Now: $42.98
Low: $42.97
High: $42.99

50 Day Range

MA: $42.86
Low: $42.48
High: $42.98

52 Week Range

Now: $42.98
Low: $22.89
High: $52.23

Volume

7,386,200 shs

Average Volume

1,924,736 shs

Market Capitalization

$4.46 billion

P/E Ratio

62.29

Dividend Yield

N/A

Beta

1.58